France vs Panama: Cause of death, by non-communicable diseases, ages 0-4, male
France
36.7%
in 2021
Panama
35.9%
in 2021
France rank
64th
Panama rank
67th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- France
- Panama
How they compare
France currently reports 36.7% against 35.9% in Panama, a difference of 0.8%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was France ahead.
France ranks 64th and Panama ranks 67th of 185 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.7% | 32.6% | 11.2% | France |
| 2010s | 37.7% | 34.5% | 3.3% | France |
| 2020s | 37.0% | 35.6% | 1.5% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, France or Panama?
- France, at 36.7% against 35.9% in Panama as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between France and Panama?
- 0.8%, with France ahead.
- How many years of comparable data are there for France and Panama?
- 6 years are reported by both, from 2000 to 2021.
- How do France and Panama rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- France ranks 64th and Panama ranks 67th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.